Not all individuals with CLL require therapy. Even with all new innovations, the iwCLL nonetheless endorses watchful observation for clients with asymptomatic condition.86 This recommendation is based on at the least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). 学習資料をアップロードして、すべてのド... https://douglasb110qfu8.get-blogging.com/profile